Masayuki Yamada, Sugako Aramaki, Tomoo Hosoe, Masahiko Kurosawa, Isao Kijima-Suda, Koichi Saito, Hiroyuki Nakazawa
Index: Anal. Sci. 24(7) , 911-4, (2008)
Full Text: HTML
Fluoxymesterone, an anabolic steroid with the 17alpha-methyl,17beta-hydroxy group, has been developed as an oral formulation for therapeutic purposes. However, it is also used illegally in racehorses to enhance racing performance. In this study, we detected 9alpha-fluoro-17,17-dimethyl-18-norandrostane-4,13-dien-11beta-ol-3-one by gas chromatography/mass spectrometry (GC/MS), which has not been reported as a fluoxymesterone metabolite so far in horse. It was synthesized for use as a reference standard, and characterized on the basis of (1)H NMR and (13)C NMR spectra, as well as GC/MS EI mass spectra of TMS derivatives. It was excreted as the main metabolite in horse urine, and its reference standard could be synthesized easily. Therefore, this metabolite could be a useful target for a doping test of fluoxymesterone in racehorses.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
Fluoxymesterone
CAS:76-43-7 |
C20H29FO3 |
Rat liver lysosomal and mitochondrial activities are modifie...
1999-02-01 [Med. Sci Sports Exerc. 31 , 243, (1999)] |
Biotransformation of 17-alkyl steroids in the equine: high-p...
1997-12-19 [J. Chromatogr. B. Biomed. Sci. Appl. 704 , 119, (1997)] |
Comparison of chemotherapy with chemohormonal therapy as fir...
2000-01-01 [J. Clin. Oncol. 18(2) , 262-6, (2000)] |
Sample size calculations for the two-sample problem using th...
2001-02-28 [Stat. Med. 20(4) , 557-79, (2001)] |
Toxic effects of anabolic-androgenic steroids in primary rat...
1995-08-01 [J. Pharmacol. Toxicol. Methods 33(4) , 187-95, (1995)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved